| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |